Research Article

Intravenously Administered Human Umbilical Cord-Derived Mesenchymal Stem Cell (HucMSC) Improves Cardiac Performance following Infarction via Immune Modulation

Figure 5

Long-term immunomodulatory effects of iv-administered HucMSC in vivo. (a) Flow cytometry analysis of T cells (CD3+% of CD45+) in the med-LNs.  ~ 4 mice for each group. (b) Flow cytometry analysis of T cells (CD3+% of CD45+) in the spleen.  ~ 4 mice for each group. (c) Representative images and quantitative analysis of CD45+ immune cells and CD45+CD3+ T cells in the peri-infarct area at 21-day post-MI.  ~ 6 mice for each group. Scale μm. (d) qRT-PCR measurement of inflammatory cytokines in the infarcted heart.  ~ 6 mice for each group. vs. MI group; vs. MI group; vs. MI group.
(a)
(b)
(c)
(d)